Literature DB >> 18247100

Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma.

Jennifer M Gillette1, C Parker Gibbs, Sheila M Nielsen-Preiss.   

Abstract

Osteosarcoma is the most common form of primary bone cancer. In this study, we established a human osteosarcoma cell line (OS 99-1) from a highly aggressive primary tumor. G-banding karyotype analysis demonstrated a large number of clonal abnormalities, as well as extensive intercellular heterogeneity. Through the use of immunologic, molecular, and biochemical analyses, we characterized protein and gene expression profiles confirming the osteogenic nature of the cells. Further evaluation indicated that OS 99-1 cells maintain the capacity to differentiate in an in vitro mineralization assay as well as form tumors in the in vivo chicken embryo model. This cell line provides a useful tool to investigate the molecular mechanisms contributing to osteosarcoma and may have the potential to serve as a culture system for studies involving bone physiology.

Entities:  

Mesh:

Year:  2008        PMID: 18247100     DOI: 10.1007/s11626-007-9075-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  26 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

Review 2.  Osteosarcoma following retinoblastoma: age at onset and latency period.

Authors:  L Chauveinc; V Mosseri; E Quintana; L Desjardins; P Schlienger; F Doz; B Dutrillaux
Journal:  Ophthalmic Genet       Date:  2001-06       Impact factor: 1.803

3.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals.

Authors:  Maria Ballester; Anna Castelló; Elena Ibáñez; Armand Sánchez; Josep M Folch
Journal:  Biotechniques       Date:  2004-10       Impact factor: 1.993

5.  Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72).

Authors:  N Rochet; J Dubousset; C Mazeau; E Zanghellini; M F Farges; H S de Novion; A Chompret; B Delpech; N Cattan; M Frenay; J Gioanni
Journal:  Int J Cancer       Date:  1999-07-19       Impact factor: 7.396

6.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.

Authors:  T Yamaguchi; J Toguchida; T Yamamuro; Y Kotoura; N Takada; N Kawaguchi; Y Kaneko; Y Nakamura; M S Sasaki; K Ishizaki
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

7.  Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines.

Authors:  S M Nielsen-Preiss; J P Quigley; J E Testa
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

8.  Imaging findings of extrapulmonary metastases of osteosarcoma.

Authors:  Seung Ja Kim; Jung-Ah Choi; Sang Hyun Lee; Ja Young Choi; Sung Hwan Hong; Hye Won Chung; Heung Sik Kang
Journal:  Clin Imaging       Date:  2004 Jul-Aug       Impact factor: 1.605

9.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

10.  Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes.

Authors:  J A Fletcher; M C Gebhardt; H P Kozakewich
Journal:  Cancer Genet Cytogenet       Date:  1994-10
View more
  7 in total

1.  BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.

Authors:  Lin Wang; Paul Park; Huina Zhang; Frank La Marca; Amy Claeson; Juan Valdivia; Chia-Ying Lin
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

2.  Establishment and cytogenetic characterization of a cell line from a pulmonary metastasis of osteosarcoma.

Authors:  Carolina Salinas-Souza; Indhira Dias Oliveira; Renato de Oliveira; Maria Teresa de Seixas Alves; Antonio Sergio Petrilli; Silvia Regina Caminada Toledo
Journal:  Cytotechnology       Date:  2012-07-26       Impact factor: 2.058

3.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

4.  Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas.

Authors:  U Basu-Roy; E Seo; L Ramanathapuram; T B Rapp; J A Perry; S H Orkin; A Mansukhani; C Basilico
Journal:  Oncogene       Date:  2011-09-19       Impact factor: 9.867

5.  Bone formation induced by BMP-2 in human osteosarcoma cells.

Authors:  Lin Wang; Paul Park; Frank La Marca; Khoi Than; Shayan Rahman; Chia-Ying Lin
Journal:  Int J Oncol       Date:  2013-07-23       Impact factor: 5.650

Review 6.  Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.

Authors:  Francesco R Evola; Luciano Costarella; Vito Pavone; Giuseppe Caff; Luca Cannavò; Andrea Sessa; Sergio Avondo; Giuseppe Sessa
Journal:  Front Pharmacol       Date:  2017-04-07       Impact factor: 5.810

7.  Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.

Authors:  Louis-Romée Le Nail; Meadhbh Brennan; Philippe Rosset; Frédéric Deschaseaux; Philippe Piloquet; Olivier Pichon; Cédric Le Caignec; Vincent Crenn; Pierre Layrolle; Olivier Hérault; Gonzague De Pinieux; Valérie Trichet
Journal:  Int J Mol Sci       Date:  2018-03-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.